a developer of pharmaceutical products
Industry Biotechnology
A.I.dvisor tells us that NVO and NONOF have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NVO and NONOF's prices will move in lockstep.
Ticker / NAME | Correlation To NVO | 1D Price Change % | ||
---|---|---|---|---|
NVO | 100% | -0.04% | ||
NONOF - NVO | 30% Poorly correlated | +1.00% | ||
HOOK - NVO | 28% Poorly correlated | -1.84% | ||
VRTX - NVO | 28% Poorly correlated | +0.25% | ||
IMRN - NVO | 28% Poorly correlated | +2.38% | ||
PHGE - NVO | 28% Poorly correlated | -1.79% | ||
More |
Ticker / NAME | Correlation To NVO | 1D Price Change % |
---|---|---|
NVO | 100% | -0.04% |
Pharmaceuticals category (305 stocks) | 37% Loosely correlated | -1.41% |